US health panel says Merck pill can prevent grave Covid infections

Covid pill Molnupiravir

The European Medicines Agency said on November 23, 2021 it may decide "within weeks" whether to approve Merck's anti-Covid pill, Lagevrio.

Photo credit: Handout | Merck & Co, Inc. | AFP

Washington,

Welcome!

You're all set to enjoy unlimited Prime content.